Efficacy of a commercial hydrolysate diet in eight cats suffering from inflammatory bowel disease or adverse reaction to food

Tijdschr Diergeneeskd. 2010 Sep 15;135(18):668-72.

Abstract

Eight of 28 cats presenting with chronic vomiting and/or diarrhoea were diagnosed as suffering from chronic enteropathy. All cats had undergone a complete diagnostic work-up, including endoscopy. Histopathology findings varied from normal, eosinophilic, to lymphoplasmacytic gastroenteritis. On the basis of findings, the cats were diagnosed with inflammatory bowel disease (IBD) or an adverse reaction to food. A hydrolysed protein diet was used as sole therapy, and clinical signs resolved within 4-8 days in all eight cats. After 2 months the cats had gained weight. A challenge trial with their previous diet resulted in recurrence of the clinical signs, which resolved in seven cats when the test diet was reintroduced. We conclude that the hydrolysed protein diet used in the current study was effective in managing these cases.

MeSH terms

  • Animal Feed / adverse effects
  • Animals
  • Cat Diseases / diagnosis
  • Cat Diseases / diet therapy*
  • Cats
  • Food Hypersensitivity / diagnosis
  • Food Hypersensitivity / diet therapy
  • Food Hypersensitivity / veterinary*
  • Inflammatory Bowel Diseases / diagnosis
  • Inflammatory Bowel Diseases / diet therapy
  • Inflammatory Bowel Diseases / veterinary*
  • Male
  • Protein Hydrolysates / therapeutic use*
  • Treatment Outcome

Substances

  • Protein Hydrolysates